BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 22217440)

  • 1. Lurasidone: a clinical overview.
    Kane JM
    J Clin Psychiatry; 2011; 72 Suppl 1():24-8. PubMed ID: 22217440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lurasidone for schizophrenia: a review of the efficacy and safety profile for this newly approved second-generation antipsychotic.
    Citrome L
    Int J Clin Pract; 2011 Feb; 65(2):189-210. PubMed ID: 21129135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lurasidone in schizophrenia: new information about dosage and place in therapy.
    Citrome L
    Adv Ther; 2012 Oct; 29(10):815-25. PubMed ID: 23001538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Short-term efficacy and safety of lurasidone in the treatment of schizophrenia].
    Samalin L; Ben Gharbia M; Garnier M; Llorca PM
    Encephale; 2014 Dec; 40(6):507-17. PubMed ID: 25453735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lurasidone for schizophrenia: what's different?
    Kantrowitz JT; Citrome L
    Expert Rev Neurother; 2012 Mar; 12(3):265-73. PubMed ID: 22364325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lurasidone for schizophrenia: a brief review of a new second-generation antipsychotic.
    Citrome L
    Clin Schizophr Relat Psychoses; 2011 Jan; 4(4):251-7. PubMed ID: 21177242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iloperidone: a clinical overview.
    Citrome L
    J Clin Psychiatry; 2011; 72 Suppl 1():19-23. PubMed ID: 22217439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lurasidone (latuda®): an atypical antipsychotic.
    Nolan SF; Roman MW
    Issues Ment Health Nurs; 2012 May; 33(5):342-3. PubMed ID: 22545643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iloperidone, asenapine, and lurasidone: a brief overview of 3 new second-generation antipsychotics.
    Citrome L
    Postgrad Med; 2011 Mar; 123(2):153-62. PubMed ID: 21474903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term safety and tolerability of lurasidone in schizophrenia: a 12-month, double-blind, active-controlled study.
    Citrome L; Cucchiaro J; Sarma K; Phillips D; Silva R; Tsuchiya S; Loebel A
    Int Clin Psychopharmacol; 2012 May; 27(3):165-76. PubMed ID: 22395527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lurasidone: a new drug in development for schizophrenia.
    Meyer JM; Loebel AD; Schweizer E
    Expert Opin Investig Drugs; 2009 Nov; 18(11):1715-26. PubMed ID: 19780705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lurasidone: a new treatment option for schizophrenia.
    Owen RT
    Drugs Today (Barc); 2011 Nov; 47(11):807-16. PubMed ID: 22146224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of lurasidone in patients with schizophrenia or schizoaffective disorder switched from other antipsychotics: a randomized, 6-week, open-label study.
    McEvoy JP; Citrome L; Hernandez D; Cucchiaro J; Hsu J; Pikalov A; Loebel A
    J Clin Psychiatry; 2013 Feb; 74(2):170-9. PubMed ID: 23473350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lurasidone: an atypical antipsychotic for schizophrenia.
    Risbood V; Lee JR; Roche-Desilets J; Fuller MA
    Ann Pharmacother; 2012; 46(7-8):1033-46. PubMed ID: 22828971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of lurasidone for patients with schizophrenia following 6 weeks of acute treatment with lurasidone, olanzapine, or placebo: a 6-month, open-label, extension study.
    Stahl SM; Cucchiaro J; Simonelli D; Hsu J; Pikalov A; Loebel A
    J Clin Psychiatry; 2013 May; 74(5):507-15. PubMed ID: 23541189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lurasidone in the treatment of acute schizophrenia: a double-blind, placebo-controlled trial.
    Nakamura M; Ogasa M; Guarino J; Phillips D; Severs J; Cucchiaro J; Loebel A
    J Clin Psychiatry; 2009 Jun; 70(6):829-36. PubMed ID: 19497249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lurasidone : in the treatment of schizophrenia.
    Sanford M
    CNS Drugs; 2013 Jan; 27(1):67-80. PubMed ID: 23264146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of published evidence reporting on the efficacy and pharmacology of lurasidone.
    McIntyre RS; Cha DS; Alsuwaidan M; McIntosh D; Powell AM; Jerrell JM
    Expert Opin Pharmacother; 2012 Aug; 13(11):1653-9. PubMed ID: 22559286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement in QTc prolongation induced by zotepine following a switch to perospirone.
    Suzuki Y; Watanabe J; Sugai T; Fukui N; Ono S; Tsuneyama N; Saito M; Someya T
    Psychiatry Clin Neurosci; 2012 Apr; 66(3):244. PubMed ID: 22443250
    [No Abstract]   [Full Text] [Related]  

  • 20. Lurasidone (Latuda) for schizophrenia.
    Med Lett Drugs Ther; 2011 Feb; 53(1358):13-4. PubMed ID: 21372761
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.